Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399

por Gentzler, Ryan D, Villaruz, Liza C, Rhee, John C, Horton, Bethany, Mock, Joseph, Hanley, Michael, Kim, Kyeongmin, Rudek, Michelle A, Phelps, Mitch A, Carducci, Michael A, Piekarz, Richard, Park, Kwon-Sik, Bullock, Timothy N, Rudin, Charles M
Publicado 2023

Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis

por Kuang, Chaoyuan, Park, Yongseok, Augustin, Ryan C., Lin, Yan, Hartman, Douglas J., Seigh, Lindsey, Pai, Reetesh K., Sun, Weijing, Bahary, Nathan, Ohr, James, Rhee, John C., Marks, Stanley M., Beasley, H. Scott, Shuai, Yongli, Herman, James G., Zarour, Hassane M., Chu, Edward, Lee, James J., Krishnamurthy, Anuradha
Publicado 2022

KRAS Amplification in Metastatic Colon Cancer is Associated with a History of Inflammatory Bowel Disease and May Confer Resistance to anti-EGFR Therapy

por Favazza, Laura A., Parseghian, Christine M., Kaya, Cihan, Nikiforova, Marina N., Roy, Somak, Wald, Abigail I., Landau, Michael S., Proksell, Siobhan S., Dueker, Jeffrey M., Johnston, Elyse R., Brand, Randall E., Bahary, Nathan, Gorantla, Vikram C., Rhee, John C., Pingpank, James F., Choudry, Haroon A., Lee, Kenneth, Paniccia, Alessandro, Ongchin, Melanie C., Zureikat, Amer H., Bartlett, David L., Singhi, Aatur D.
Publicado 2020